Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$301K Sell
568
-32
-5% -$14.8K 0.05% 183
2026
Q1
$288K Buy
+600
New +$307K 0.05% 184
2025
Q3
Sell
-773
Closed -$243K 259
2025
Q2
$243K Buy
773
+15
+2% +$4.5K 0.05% 208
2025
Q1
$231K Sell
758
-75
-9% -$25.2K 0.05% 211
2024
Q4
$277K Buy
+833
New +$283K 0.06% 194

Other funds holding MEDP

SkyOak Wealth's MEDP Position: Q2 2026 in Review

SkyOak Wealth reduced its Medpace (MEDP) stake by 5.3% in Q2 2026, selling an estimated $14.8K and leaving 568 shares worth $301K. The position accounts for 0.05% of the portfolio, ranked #183.

SkyOak Wealth first reported a position in MEDP in Q4 2024 and has held it in 5 quarters since. 694 funds tracked by Wall St. Rank hold MEDP as of Q2 2026.

  • SkyOak Wealth held 568 shares of Medpace worth $301K as of Q2 2026.
  • SkyOak Wealth sold 32 Medpace shares in Q2 2026, an estimated $14.8K.
  • Medpace made up 0.05% of SkyOak Wealth's portfolio in Q2 2026, its #183 holding.
  • SkyOak Wealth first reported a position in Medpace in Q4 2024 and has held it in 5 quarters since.
  • 694 funds tracked by Wall St. Rank held Medpace as of Q2 2026.

Based on SkyOak Wealth's 13F filing for Q2 2026, filed 30 Jul 2026.